wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37697125-36D04F91-A9A2-44FA-B81A-B6A7BA2D0E09
Q37697125-36D04F91-A9A2-44FA-B81A-B6A7BA2D0E09
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37697125-36D04F91-A9A2-44FA-B81A-B6A7BA2D0E09
Is there a benefit of first- or second-line crizotinib in locally advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer? a meta-analysis.
P2860
Q37697125-36D04F91-A9A2-44FA-B81A-B6A7BA2D0E09
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37697125-36D04F91-A9A2-44FA-B81A-B6A7BA2D0E09
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
920017edee80975ea22999e0e7083f29e7fde5f4
P2860
Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein